Jensen Investment Management Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 1,874,003 shares of the healthcare conglomerate’s stock after selling 60,785 shares during the period. UnitedHealth Group comprises approximately 4.8% of Jensen Investment Management Inc.’s holdings, making the stock its 6th largest holding. Jensen Investment Management Inc. owned about 0.19% of UnitedHealth Group worth $347,478,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. RB Capital Management LLC raised its stake in UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after buying an additional 7 shares during the period. Altfest L J & Co. Inc. raised its stake in UnitedHealth Group by 0.3% during the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after buying an additional 10 shares during the period. Parkside Financial Bank & Trust raised its stake in UnitedHealth Group by 1.4% during the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the period. Budros Ruhlin & Roe Inc. raised its stake in UnitedHealth Group by 0.8% during the 1st quarter. Budros Ruhlin & Roe Inc. now owns 1,832 shares of the healthcare conglomerate’s stock worth $301,000 after buying an additional 15 shares during the period. Finally, Hanson McClain Inc. raised its stake in UnitedHealth Group by 1.7% during the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $147,000 after buying an additional 15 shares during the period. Hedge funds and other institutional investors own 86.00% of the company’s stock.
In other news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. In the last 90 days, insiders sold 72,149 shares of company stock worth $14,212,342. 0.89% of the stock is owned by company insiders.
Several brokerages recently commented on UNH. Royal Bank Of Canada reaffirmed a “buy” rating and set a $212.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 20th. Citigroup Inc. increased their target price on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Sanford C. Bernstein reiterated an “outperform” rating and set a $210.00 target price (up previously from $190.00) on shares of UnitedHealth Group in a report on Saturday, July 22nd. Cowen and Company reiterated an “outperform” rating and set a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 target price for the company in a report on Tuesday, August 1st. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $216.65.
ILLEGAL ACTIVITY WARNING: This news story was first reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.truebluetribune.com/2017/11/14/jensen-investment-management-inc-has-347-48-million-stake-in-unitedhealth-group-incorporated-unh.html.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at $212.66 on Tuesday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a one year low of $147.04 and a one year high of $213.93. The firm has a market cap of $204,541.08, a price-to-earnings ratio of 21.99, a P/E/G ratio of 1.57 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.17 earnings per share. analysts forecast that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be issued a $0.75 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.41%. UnitedHealth Group’s payout ratio is 33.26%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.